Document is current
Any future updates will be listed below
-
Authors
Liu, Dan-Dan
Ding, Wenlong https://orcid.org/0000-0001-9681-2027
Cheng, Jin-Tao https://orcid.org/0009-0001-7073-9404
Wei, Qiushi https://orcid.org/0000-0001-8162-8796
Lin, Yinuo
Zhu, Tian-Yi
Tian, Jing
Sun, Ke
Zhang, Long https://orcid.org/0000-0001-8139-0474
Lu, Peilong https://orcid.org/0000-0001-5894-9268
Yang, Fan https://orcid.org/0000-0002-0520-5254
Liu, Chao https://orcid.org/0000-0002-5286-6944
Tang, Shibing https://orcid.org/0000-0001-8592-3477
Yang, Bing https://orcid.org/0000-0001-6739-2932
- License Information
-
More Information
Article History
Received: 28 January 2024
Accepted: 10 June 2024
First Online: 18 June 2024
Competing interests
: The authors declare the following competing interests: B.Y., S.T., D.D.L., Zhejiang University and Guangzhou Institutes of Biomedicine and Health have filed a patent application (Chinese patent application number: 2024105555109) on the design and application of the fluorosulfate containing tyrosine analog eFSY. All other authors declare no competing interests.
